A new flu vaccine has been approved in the US for adults 50+, bringing mRNA technology into seasonal flu prevention and ...

An mRNA flu vaccine that updates close to season has finally been approved. Its speed means nothing until officials move a decades-old strain deadline ...

People looking to get their annual flu shot this fall may find a new option alongside the usual vaccines: an mRNA flu shot. Not everyone is eligible, however.

For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug ...

On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults aged 65 and older.

Newswise — New York, NY — [April 29, 2026] — A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, ...

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

Moderna's MRNA.O mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on ...

The answer may lie in what mRNA does inside the immune system. Covid-19 mRNA vaccines deliver genetic instructions that allow ...

Singapore is advancing mRNA influenza vaccine development to boost pandemic preparedness and support global vaccine ...

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, ...

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot. The ...